271 related articles for article (PubMed ID: 27717667)
1. Global tobacco prevention and control in relation to a cardiovascular health promotion and disease prevention framework: A narrative review.
Carroll AJ; Labarthe DR; Huffman MD; Hitsman B
Prev Med; 2016 Dec; 93():189-197. PubMed ID: 27717667
[TBL] [Abstract][Full Text] [Related]
2. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and public health policy of tobacco use and cardiovascular disorders in low- and middle-income countries.
Saleheen D; Zhao W; Rasheed A
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1811-9. PubMed ID: 25035346
[TBL] [Abstract][Full Text] [Related]
4. The impact and relevance of tobacco control research in low-and middle-income countries globally and to the US.
Berg CJ; Fong GT; Thrasher JF; Cohen JE; Maziak W; Lando H; Drope J; Mejia R; Barnoya J; Nakkash R; Salloum RG; Parascandola M
Addict Behav; 2018 Dec; 87():162-168. PubMed ID: 30041132
[TBL] [Abstract][Full Text] [Related]
5. Practical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.
Le Goff D; Aerts N; Odorico M; Guillou-Landreat M; Perraud G; Bastiaens H; Musinguzi G; Le Reste JY; Barais M
Int J Behav Nutr Phys Act; 2023 Jul; 20(1):93. PubMed ID: 37507692
[TBL] [Abstract][Full Text] [Related]
6. Success counteracting tobacco company interference in Thailand: an example of FCTC implementation for low- and middle-income countries.
Charoenca N; Mock J; Kungskulniti N; Preechawong S; Kojetin N; Hamann SL
Int J Environ Res Public Health; 2012 Apr; 9(4):1111-34. PubMed ID: 22690186
[TBL] [Abstract][Full Text] [Related]
7. Quality Improvement for Cardiovascular Disease Care in Low- and Middle-Income Countries: A Systematic Review.
Lee ES; Vedanthan R; Jeemon P; Kamano JH; Kudesia P; Rajan V; Engelgau M; Moran AE
PLoS One; 2016; 11(6):e0157036. PubMed ID: 27299563
[TBL] [Abstract][Full Text] [Related]
8. Promotion of smoking cessation in developing countries: a framework for urgent public health interventions.
Abdullah AS; Husten CG
Thorax; 2004 Jul; 59(7):623-30. PubMed ID: 15223875
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular health in low- and middle-income countries.
Huffman MD
Curr Probl Cardiol; 2014 Nov; 39(11):399-419. PubMed ID: 25445166
[TBL] [Abstract][Full Text] [Related]
10. Framework Convention on Tobacco Control 2030-A Program to Accelerate the Implementation of World Health Organization Framework Convention for Tobacco Control in Low- and Middle-Income Countries: A Mixed-Methods Evaluation.
Siddiqi K; Elsey H; Khokhar MA; Marshall AM; Pokhrel S; Arora M; Crankson S; Mehra R; Morello P; Collin J; Fong GT
Nicotine Tob Res; 2023 May; 25(6):1074-1081. PubMed ID: 36757326
[TBL] [Abstract][Full Text] [Related]
11. The Framework Convention on Tobacco Control and health promotion: strengthening the ties.
Lin V
Glob Health Promot; 2010 Mar; 17(1 Suppl):76-80. PubMed ID: 20595358
[TBL] [Abstract][Full Text] [Related]
12. Tobacco Control Progress in Low and Middle Income Countries in Comparison to High Income Countries.
Anderson CL; Becher H; Winkler V
Int J Environ Res Public Health; 2016 Oct; 13(10):. PubMed ID: 27783060
[TBL] [Abstract][Full Text] [Related]
13. Health promotion and cardiovascular disease prevention in sub-Saharan Africa.
Sampson UK; Amuyunzu-Nyamongo M; Mensah GA
Prog Cardiovasc Dis; 2013; 56(3):344-55. PubMed ID: 24267442
[TBL] [Abstract][Full Text] [Related]
14. Converging research needs across framework convention on tobacco control articles: making research relevant to global tobacco control practice and policy.
Leischow SJ; Ayo-Yusuf O; Backinger CL
Nicotine Tob Res; 2013 Apr; 15(4):761-6. PubMed ID: 22990225
[TBL] [Abstract][Full Text] [Related]
15. Effects of tobacco control policy on cardiovascular morbidity and mortality in Russia.
Gambaryan M; Reeves A; Deev A; Popovich M; Drapkina O; Snell A; Stuckler D; Mauer-Stender K; Mikkelsen B; Boytsov S
Eur J Public Health; 2018 Oct; 28(suppl_2):14-16. PubMed ID: 30371836
[TBL] [Abstract][Full Text] [Related]
16. Evidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association.
Labarthe DR; Goldstein LB; Antman EM; Arnett DK; Fonarow GC; Alberts MJ; Hayman LL; Khera A; Sallis JF; Daniels SR; Sacco RL; Li S; Ku L; Lantz PM; Robinson JG; Creager MA; Van Horn L; Kris-Etherton P; Bhatnagar A; Whitsel LP;
Circulation; 2016 May; 133(18):e615-53. PubMed ID: 27045139
[TBL] [Abstract][Full Text] [Related]
17. Transnational tobacco companies and the mechanism of externalization: A realist synthesis.
Mlinarić M; Schreuders M; Graen L; Lessenich S
Health Place; 2020 Jan; 61():102240. PubMed ID: 31734138
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania.
Ngalesoni F; Ruhago G; Mayige M; Oliveira TC; Robberstad B; Norheim OF; Higashi H
PLoS One; 2017; 12(8):e0182113. PubMed ID: 28767722
[TBL] [Abstract][Full Text] [Related]
19. [Current and emerging issues in tobacco prevention and control].
Reynales-Shigematsu LM; Roa-Rodríguez R; Barrington-Trimis JL; Blanco-Marquizo A
Salud Publica Mex; 2019; 61(4):436-447. PubMed ID: 31430086
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]